0 items USD 0.00Search
Your search for "delveinsight diabetic peripheral neuropathy pipeline insights 2015" gave back 55121 results.
Summary HeyReport estimates that the Chemotherapy Induced Peripheral Neuropathy Treatment market size will grow from xxx Million USD in 2020 to xxxx...
Catalog:
HYR
July 2021
Price: USD 2,000.00
Peripheral neuropathy is a set of symptoms caused by any damage to the nerves that are away from the brain and spinal cord. Peripheral neuropathy is...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Peripheral neuropathy is a set of symptoms caused by any damage to the nerves that are away from the brain and spinal cord. Peripheral neuropathy is...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
CIPN is a common adverse effect of several cancer therapies including taxanes and platinum drugs. Symptoms include decreased sensation and tingling...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
The global Chemotherapy Induced Peripheral Neuropathy Treatment market size was valued at USD 1723.6 million in 2023 and is forecast to a readjusted...
Catalog:
GIR
January 2024
Price: USD 3,480.00
CIPN is a common adverse effect of several cancer therapies including taxanes and platinum drugs. Symptoms include decreased sensation and tingling...
Catalog:
LPI
January 2023
Price: USD 3,660.00
The global Chemotherapy Induced Peripheral Neuropathy Treatment market size was valued at US$ 1638.7 million in 2023. With growing demand in...
Catalog:
LPI
January 2024
Price: USD 3,660.00
CIPN is a common adverse effect of several cancer therapies including taxanes and platinum drugs. Symptoms include decreased sensation and tingling...
Catalog:
MRRPB5
January 2023
Price: USD 4,000.00
Peripheral neuropathy is a set of symptoms caused by any damage to the nerves that are away from the brain and spinal cord. Peripheral neuropathy is...
Catalog:
GIR
January 2023
Price: USD 3,480.00
CIPN is a common adverse effect of several cancer therapies including taxanes and platinum drugs. Symptoms include decreased sensation and tingling...
Catalog:
MRRPB5
September 2023
Price: USD 4,900.00
“Diabetic Foot Ulcer (DFU) Pipeline Analysis” gives comprehensive insights on the various drugs being developed for the treatment of DFU. The report...
Catalog:
IQ4I
December 2018
Price: USD 3,600.00
CIPN is a common adverse effect of several cancer therapies including taxanes and platinum drugs. Symptoms include decreased sensation and tingling...
Catalog:
GIR
January 2023
Price: USD 3,480.00
Diabetic neuropathies are nerve damaging disorders associated with diabetes mellitus. These conditions are thought to result from a diabetic...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The global Diabetic Autonomic Neuropathy Drug market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to...
Catalog:
LPI
June 2023
Price: USD 3,660.00
CIPN is a common adverse effect of several cancer therapies including taxanes and platinum drugs. Symptoms include decreased sensation and tingling...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
